Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula
Not Applicable
Recruiting
- Conditions
- Functional Gastrointestinal Disorders
- Interventions
- Dietary Supplement: New infant formula
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 139
- Registration Number
- NCT06488274
- Locations
- ๐ซ๐ท
Site 02, Nice, France
๐ซ๐ทSite 04, Paris, France
๐ซ๐ทSite 03, Toulon, France
Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
Not Applicable
Active, not recruiting
- Conditions
- Cow's Milk Allergy
- Interventions
- Dietary Supplement: Test FormulaDietary Supplement: Placebo Formula
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 70
- Registration Number
- NCT06481280
- Locations
- ๐ง๐ช
Private practice Elena BRADATAN, Namur, Begium, Belgium
๐ฎ๐นUniversity Hospital - Umberto I Sapienza, Roma, Italy
Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation
Not Applicable
Recruiting
- Conditions
- Functional Constipation
- Interventions
- Dietary Supplement: Standard formulaDietary Supplement: new infant formula
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2022-11-07
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 80
- Registration Number
- NCT05340712
- Locations
- ๐ฎ๐น
University of Naples "Federico II", Napoli, Italy
๐ฎ๐นUniversity of Campania Luigi Vanvitelli, Napoli, Italy
Evaluation of an Adapted Formula on Atopic Dermatitis.
Not Applicable
Active, not recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Dietary Supplement: tested formula with fiberDietary Supplement: Control
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 126
- Registration Number
- NCT05318300
- Locations
- ๐ง๐ช
Center_13, Namur, Belgium
๐ซ๐ทCenter_05, Nice, France
๐ง๐ชCenter_14, Thuin, Belgium
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)
Not Applicable
- Conditions
- Gastroesophageal Reflux in Children
- Interventions
- Other: Experimental Infant formulaOther: Infant formula thickened with locust bean gum
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 346
- Registration Number
- NCT04358146
Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins
Not Applicable
Completed
- Conditions
- Cow Milk Allergy
- Interventions
- Dietary Supplement: rice formulaDietary Supplement: placebo
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 72
- Registration Number
- NCT03557671
- Locations
- ๐ฎ๐น
University of Naples Federico II, Naples, Italy
๐ซ๐ทHopital Trousseau, Paris, France
๐ซ๐ทHรดpital Saint Vincent de Paul - GHICL, Lille, France
SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)
Not Applicable
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- Dietary Supplement: Thickened infant formula
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT02710955
- Locations
- ๐ง๐ช
Universitair Ziekenhuis, Brussels, Belgium
Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula
Phase 3
Completed
- Conditions
- Cow Milk Allergy
- Interventions
- Dietary Supplement: Amino acid formulaDietary Supplement: Extensively Hydrolyzed formula
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 30
- Registration Number
- NCT02711163
- Locations
- ๐ฎ๐น
Umberto I university hospital, Roma, Italy
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula
Phase 3
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- Dietary Supplement: New thickened formula
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2015-04-24
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT02425423
- Locations
- ๐ซ๐ท
Pediatricians, France, France
๐ง๐ชUniversitair Ziekenhuis, Brussel, Belgium
Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy
Phase 3
Completed
- Conditions
- Cow Milk Allergy
- Interventions
- Dietary Supplement: Extensively Hydrolyzed formula
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2015-01-30
- Lead Sponsor
- United Pharmaceuticals
- Target Recruit Count
- 32
- Registration Number
- NCT02351531
- Locations
- ๐ซ๐ท
Necker Children's Hospital, Paris, France
๐ฎ๐นUniversity of Naples Federico II, Naples, Italy
๐ง๐ชCentre Hospitalier Rรฉgional, Namur, Belgium
ยฉ Copyright 2025. All Rights Reserved by MedPath